Roses AD - Search Results

1

Using genetics to enable studies on the prevention of Alzheimer's disease.

Crenshaw DG, Gottschalk WK, Lutz MW, Grossman I, Saunders AM, Burke JR, Welsh-Bohmer KA, Brannan SK, Burns DK, Roses AD. Crenshaw DG, et al. Among authors: roses ad. Clin Pharmacol Ther. 2013 Feb;93(2):177-85. doi: 10.1038/clpt.2012.222. Epub 2012 Nov 7. Clin Pharmacol Ther. 2013. PMID: 23249780 Free PMC article.

2

New applications of disease genetics and pharmacogenetics to drug development.

Roses AD, Saunders AM, Lutz MW, Zhang N, Hariri AR, Asin KE, Crenshaw DG, Budur K, Burns DK, Brannan SK. Roses AD, et al. Curr Opin Pharmacol. 2014 Feb;14:81-9. doi: 10.1016/j.coph.2013.12.002. Epub 2014 Jan 3. Curr Opin Pharmacol. 2014. PMID: 24565016 Free article. Review.

3

New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.

Lutz MW, Crenshaw D, Welsh-Bohmer KA, Burns DK, Roses AD. Lutz MW, et al. Among authors: roses ad. Curr Neurol Neurosci Rep. 2016 May;16(5):48. doi: 10.1007/s11910-016-0643-8. Curr Neurol Neurosci Rep. 2016. PMID: 27039903 Review.

4

A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease.

Lutz MW, Sundseth SS, Burns DK, Saunders AM, Hayden KM, Burke JR, Welsh-Bohmer KA, Roses AD. Lutz MW, et al. Among authors: roses ad. Alzheimers Dement (N Y). 2016 Jan 1;2(1):30-44. doi: 10.1016/j.trci.2015.12.002. Alzheimers Dement (N Y). 2016. PMID: 27047990 Free PMC article.

5

APOE is a major susceptibility gene for Alzheimer's disease.

Roses AD, Saunders AM. Roses AD, et al. Curr Opin Biotechnol. 1994 Dec;5(6):663-7. doi: 10.1016/0958-1669(94)90091-4. Curr Opin Biotechnol. 1994. PMID: 7765750 Review.

6

Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease.

Roses AD, Saunders AM. Roses AD, et al. Int Psychogeriatr. 1997;9 Suppl 1:277-88; discussion 317-21. doi: 10.1017/s1041610297005012. Int Psychogeriatr. 1997. PMID: 9447448

7

Genetics of Alzheimer's disease.

Burke JR, Roses AD. Burke JR, et al. Among authors: roses ad. Int J Neurol. 1991-1992;25-26:41-51. Int J Neurol. 1991. PMID: 11980062 Review.

8

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.

Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM. Roses AD, et al. Pharmacogenomics J. 2010 Oct;10(5):375-84. doi: 10.1038/tpj.2009.69. Epub 2009 Dec 22. Pharmacogenomics J. 2010. PMID: 20029386 Free PMC article.

9

Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease.

Roses A, Sundseth S, Saunders A, Gottschalk W, Burns D, Lutz M. Roses A, et al. Alzheimers Dement. 2016 Jun;12(6):687-94. doi: 10.1016/j.jalz.2016.03.015. Epub 2016 May 4. Alzheimers Dement. 2016. PMID: 27154058 Free article. Review.

10

Analysis of European mitochondrial haplogroups with Alzheimer disease risk.

van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy P, Gilbert JR, Haines JL, Vance JM, Pericak-Vance MA. van der Walt JM, et al. Among authors: roses ad. Neurosci Lett. 2004 Jul 15;365(1):28-32. doi: 10.1016/j.neulet.2004.04.051. Neurosci Lett. 2004. PMID: 15234467

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page